Pharmacological modulation of Sigma-1 receptor ameliorates pathological neuroinflammation in rats with diabetic neuropathic pain via the AKT/GSK-3β/NF-κB pathway
Open Access
- 25 January 2025
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 221, 111226
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 68 references indexed in Scilit:
- Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18Neurochemical Research, 2018
- Nrf2: a potential therapeutic target for diabetic neuropathyInflammopharmacology, 2017
- Pharmacological Modulation of the Sigma 1 Receptor and the Treatment of Pain2017
- Stimulation of the Sigma-1 Receptor and the Effects on Neurogenesis and Depressive Behaviors in Mice2017
- Sigma-1 Receptor and Pain2017
- Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in ratsEuropean journal of pain, 2016
- Possible involvement of the sigma-1 receptor chaperone in chemotherapeutic-induced neuropathic painSynapse, 2015
- Sigma-1 Receptor Modulates Neuroinflammation After Traumatic Brain InjuryCellular and Molecular Neurobiology, 2015
- Effects of a Selective Sigma 1 Antagonist Compound on Inflammatory PainInflammation, 2013
- Sigma receptors suppress multiple aspects of microglial activationGlia, 2008